We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses. MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.
Completed $5.8 million private placement financing at 25% premium Upcoming presentation of agenT-797 in severe respiratory distress at the American Thoracic Society (ATS)AACR presentation reported...
Financing of $5.8 Million at a 25% premium will help advance the clinical development of MiNK-215, an armored-FAP-CAR-iNKTGKCC, LLC joins as a new investor with Katie Chudnovsky appointed as a...
NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of...
MiNK-215 eliminated MSS colorectal cancer liver metastases in human organoid modelsMiNK-215 exhibits potent anti-tumor activity through multiple mechanisms including immune activation NEW YORK...
U.S. index futures are showing an uptrend in Thursday’s pre-market, driven by the record close of the three major indexes in the previous session and the more “dovish” stance...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1194 | 12.8387096774 | 0.93 | 1.3 | 0.86 | 1182328 | 0.99821375 | CS |
4 | 0.1311 | 14.2763802679 | 0.9183 | 1.3 | 0.86 | 333657 | 0.98952557 | CS |
12 | 0.1094 | 11.6382978723 | 0.94 | 1.9 | 0.78 | 194990 | 1.09414514 | CS |
26 | 0.0094 | 0.903846153846 | 1.04 | 1.9 | 0.75 | 119083 | 1.06346504 | CS |
52 | -0.6506 | -38.2705882353 | 1.7 | 3.34 | 0.75 | 100924 | 1.40664477 | CS |
156 | -10.9906 | -91.2840531561 | 12.04 | 22.155 | 0.75 | 120418 | 2.90466566 | CS |
260 | -10.9906 | -91.2840531561 | 12.04 | 22.155 | 0.75 | 120418 | 2.90466566 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions